Dibucaine ointment

DLA Troop Support Medical (Medical Supply Chain) is soliciting quotes for six packages of Dibucaine Ointment, NSN 6505-00-299-9535, under request for quotation SPE2DP27T0002, with quotes due October 7, 2026. No set-aside is used, so the procurement is open to all quoters.

Quotes must be submitted through DIBBS, and the solicitation type is Fast Auto Evaluation. Delivery is required in 20 days to the bulk break point at MD Co Medical Company in Starke, Florida, on FOB Destination terms with inspection and acceptance at destination.

The product must be FDA-regulated, a 1 percent topical ointment supplied in collapsible tubes with rectal applicators for external use only, with a 36-month non-extendable shelf life. Packaging must comply with Medical Marking Standard No. 1 and MIL-STD-2073-1E, and hazard warning labels per the Hazard Communication Standard are required.

Quotes above the micro-purchase threshold are subject to DFARS Buy American requirements, and Berry Amendment compliance applies at the reduced threshold of $150,000. Quotes must include standard FAR and DFARS representations and certifications, including covered telecommunications equipment prohibitions and small business status representations. The solicitation incorporates the DLA Master Solicitation for Automated Simplified Acquisitions, Revision 105, dated May 20, 2026.

Recent awards for this item to CAGE code 3W8H0 ranged from $6.50 to $7.62 per package, with the most recent award dated September 29, 2026.